SNCG and synucleinopathy: Furthermore, the capability of α-synuclein to form different high-molecular-weight assemblies was linked to the ability of this protein to trigger different synucleinopathies [45], as demonstrated by the direct observation of the induction of different synucleinopathies after injection of the different α-synuclein aggregated forms (oligomers, ribbons, and fibrils) in the rat brain [46].